108 related articles for article (PubMed ID: 478338)
1. [Comparison of the results of single-drug and combination chemotherapy of advanced ovarian cancer after 1 year].
Sablińska B; Cześnin K; Ploch E
Ginekol Pol; 1979 Jun; 50(6):501-5. PubMed ID: 478338
[No Abstract] [Full Text] [Related]
2. Combination v. sequential therapy with melphalan, 5-fluorouracil and methotrexate for advanced ovarian cancer.
Miller AB; Klaassen DJ; Boyes DA; Dodds DJ; Gerulath A; Kirk ME; Levitt M; Pearson JG; Wall C
Can Med Assoc J; 1980 Sep; 123(5):365-71. PubMed ID: 7020903
[TBL] [Abstract][Full Text] [Related]
3. Preliminary report of a clinical trial of the treatment of patients with advanced stage III and IV ovarian cancer with melphalan, 5-fluorouracil, and methotrexate in combination and sequentially: a study of the Clinical Trials Group of the National Cancer Institute of Canada.
Klaassen DJ; Boyes DA; Gerulath A; Levitt M; Miller AB; Pearson JG
Cancer Treat Rep; 1979 Feb; 63(2):289-95. PubMed ID: 376135
[No Abstract] [Full Text] [Related]
4. Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy.
Young RC; Chabner BA; Hubbard SP; Fisher RI; Bender RA; Anderson T; Simon RM; Canellos GP; DeVita VT
N Engl J Med; 1978 Dec; 299(23):1261-6. PubMed ID: 101843
[TBL] [Abstract][Full Text] [Related]
5. Single agent vs combination chemotherapy in the treatment of ovarian cancer.
Barlow JJ; Piver MS
Obstet Gynecol; 1977 May; 49(5):609-11. PubMed ID: 850579
[TBL] [Abstract][Full Text] [Related]
6. [Advanced epithelial cancers of the ovary: results of 4 chemotherapy protocols (110 cases)].
Israël L; Lepage E; Breau JL; Aguilera J
Bull Cancer; 1982; 69(5):426-33. PubMed ID: 6891902
[TBL] [Abstract][Full Text] [Related]
7. Malignant teratoma of the ovary: prognostic factors and treatment.
Curry SL; Smith JP; Gallagher HS
Am J Obstet Gynecol; 1978 Aug; 131(8):845-9. PubMed ID: 686082
[TBL] [Abstract][Full Text] [Related]
8. Treatment of women with disseminated or recurrent advanced ovarian cancer with melphalan alone in combination with 5-fluorouracil and dactinomycin or with the combination of cytoxan, 5-fluorouracil and dactinomycin.
Park RC; Blom J; Disaia PJ; Lagasse LD; Blessing JA
Cancer; 1980 May; 45(10):2529-42. PubMed ID: 7378989
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy in curable breast cancer].
Seradour B; Thomas M
J Gynecol Obstet Biol Reprod (Paris); 1978 Mar; 7(2):175-82. PubMed ID: 353124
[No Abstract] [Full Text] [Related]
10. Chemotherapy of ovarian cancer. New approaches to treatment.
Smith JP; Rutledge F; Wharton JT
Cancer; 1972 Dec; 30(6):1565-71. PubMed ID: 4345098
[No Abstract] [Full Text] [Related]
11. Controlled prospective trial of combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil for the treatment of advanced ovarian cancer: a preliminary report.
Bruckner HW; Pagano M; Falkson G; Creech R; Arseneau JC; Horton J; Brodovsky H; Davis TE; Slayton RW; Greenspan E
Cancer Treat Rep; 1979 Feb; 63(2):297-9. PubMed ID: 376136
[No Abstract] [Full Text] [Related]
12. [Chemotherapy of testicular tumors].
Cortes Funes H; Leiva Galvis O
Actas Urol Esp; 1981; 5(5):259-72. PubMed ID: 6174033
[No Abstract] [Full Text] [Related]
13. [Chemotherapic management of genitomammary tumors].
Sarría JA; Irigoyen ML; Cismondi B
Rev Fac Cien Med Univ Nac Cordoba; 1981; 39(1-4):3-16. PubMed ID: 6897122
[No Abstract] [Full Text] [Related]
14. Combination chemotherapy in advanced breast cancer. A report of the Working Party of the Multicentre Cancer Chemotherapy Group.
Spittle MF; Bates TD; Kitchen G; Nicol NT; Wheeler T; Edelstyn G; MacRae KD; Ostrowski MJ
Clin Oncol; 1980 Jun; 6(2):153-7. PubMed ID: 7408282
[No Abstract] [Full Text] [Related]
15. [Principle products used in chemotherapy. Administration methods].
Boillon C; Olivro A; Lemerle J
Soins; 1979 Aug 5-20; 24(15-16):51-9. PubMed ID: 90390
[No Abstract] [Full Text] [Related]
16. [A randomized clinical trial of cyclophosphamide versus adriamycin, cyclophosphamide, 5-fluorouracil and methotrexate in advanced ovarian carcinoma--a preliminary report ].
Chylak V; Ilijas M; Krusić J; Kolarić K
Lijec Vjesn; 1982; 104(3-4):120-2. PubMed ID: 6750298
[No Abstract] [Full Text] [Related]
17. [Early diagnosis and effective treatment of ovarian cancer].
Sawada M; Matsui Y; Okudaira Y
Gan To Kagaku Ryoho; 1983 May; 10(5):1251-8. PubMed ID: 6191676
[TBL] [Abstract][Full Text] [Related]
18. The dilemma regarding postoperative chemotherapy in primary carcinoma of the colon.
Weiss RB; DeVita VT
Surg Gynecol Obstet; 1979 Aug; 149(2):267-71. PubMed ID: 380029
[No Abstract] [Full Text] [Related]
19. Chemotherapy of ovarian cancer.
Dimitriades M; Papadimitriou GC; Razis DV; Panopoulos C; Midoulas N
Int Surg; 1978 Feb; 63(2):81-3. PubMed ID: 632023
[TBL] [Abstract][Full Text] [Related]
20. CCNU, melphalan, methotrexate, and prednisone (CAMP) versus cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in the treatment of advanced breast cancer in postmenopausal women.
Salimtschik M; Snel S; Havsteen H; Dombernowsky P; Mouridsen HT
Cancer Treat Rep; 1980; 64(4-5):635-7. PubMed ID: 7000346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]